neurotransmitter agents

Preferred Label : neurotransmitter agents;

MeSH definition : Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.;

MeSH synonym : Neurotransmitter Agent;

CISMeF synonym : agents, neurotransmitter;

MeSH hyponym : neurotransmitters; neuroregulators; neurosteroids; neurohumors; neurohormones; neuromodulators; Neuroregulator; Neuromodulator; Transmitter Substances, Nerve; Substances, Nerve Transmitter; Nerve Transmitter Substances; Neurotransmitter; Neurohumor; Nerve Transmitter Substance; Substance, Nerve Transmitter; Transmitter Substance, Nerve; Neurohormone;

MeSH annotation : general; prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Neurotransmitter;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D018377;

UMLS CUI

C0243051;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- NT5E wt Allele [NCIt concept]
- NTS wt Allele [NCIt concept]
- Neurotransmitter [FMA entity]
- Nuchal Translucency Screen [NCIt concept]
- Tyrosine Nitration [NCIt concept]
- neurotransmitter [Artificial nutrition thesaurus concept]
Currated CISMeF NLP mapping
- Neurotransmitter [NCIt concept]
- Neurotransmitter (substance) [SNOMED CT concept]
- neurotransmitter, nos [SNOMED Notion]
Indexing information
- Flp-2 protein, C elegans [MeSH Supplementary Concept]
- SLC6A20 protein, human [MeSH Supplementary Concept]
- cocaine- and amphetamine-regulated transcript protein [MeSH Supplementary Concept]
- credneramide A [MeSH Supplementary Concept]
- credneramide B [MeSH Supplementary Concept]
- cysteine sulfinic acid [MeSH Supplementary Concept]
- disprocynium 24 [MeSH Supplementary Concept]
- glyceryl 2-arachidonate [MeSH Supplementary Concept]
- system N protein 1 [MeSH Supplementary Concept]
Metaterm(s)
- neurology [CISMeF Metaterm]
Record concept(s)
- neurohormones [MeSH concept]
- neurohumors [MeSH concept]
- neuromodulators [MeSH concept]
- neuroregulators [MeSH concept]
- neurotransmitter agents [MeSH concept]
- neurotransmitters [MeSH concept]
See also
- neurotoxins [MeSH Descriptor]
See also (suggested by CISMeF)
- autacoids [MeSH Descriptor]
- neuroimmunomodulation [MeSH Descriptor]
- receptors, neurotransmitter [MeSH Descriptor]
- synaptic transmission [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-chloronaphthalen-1-yl)methanone [MeSH Supplementary Concept]
- (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-iodonaphthalen-1-yl)methanone [MeSH Supplementary Concept]
- (6-(6-(3-ethylureido)-9H-purin-9-yl)-2-styryltetrahydrofuro(3,4-d)(1,3)dioxol-4-yl)methyl dihydrogen phosphate [MeSH Supplementary Concept]
- (7-(2-(4-difluorophenyl)-1-piperazinyl)ethyl)-2-(2-furanyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine [MeSH Supplementary Concept]
- (alpha-carboxycyclopropyl)glycine [MeSH Supplementary Concept]
- 1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine [MeSH Supplementary Concept]
- 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine [MeSH Supplementary Concept]
- 1,3-dipropyl-8-(4-sulfophenyl)xanthine [MeSH Supplementary Concept]
- 1,3-dipropyl-8-cyclopentylxanthine [MeSH Supplementary Concept]
- 1-((7-methyl-2-phenylimidazo(1,2-a)(1,3,5)triazin-4-yl)amino)acetone [MeSH Supplementary Concept]
- 1-(N,O-bis(isoquinolinesulfonyl)-N-methyltyrosyl)-4-(4-fluorophenyl)piperazine [MeSH Supplementary Concept]
- 1-aminoindan-1,5-dicarboxylic acid [MeSH Supplementary Concept]
- 1-benzyl-3-propyl-1H,3H-pyrido(2,1-f)purine-2,4-dione [MeSH Supplementary Concept]
- 1-benzyl-7-methyl-3-propyl-1H,8H-imidazo(2,1-f)purine-2,4-dione [MeSH Supplementary Concept]
- 1-butyl-3-(3-hydroxypropyl)-8-(3-noradamantyl)xanthine [MeSH Supplementary Concept]
- 1-butyl-8-(4-((4-nitrophenoxy)sulfonyl)phenyl)xanthine [MeSH Supplementary Concept]
- 1-hydroxy-3-amino-2-pyrrolidone [MeSH Supplementary Concept]
- 1-propyl-8-(4-((4-nitrophenoxy)sulfonyl)phenyl)xanthine [MeSH Supplementary Concept]
- 1-propyl-8-(4-sulfophenyl)xanthine [MeSH Supplementary Concept]
- 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate [MeSH Supplementary Concept]
- 2'-deoxyribose-N6-cyclopentyladenosine [MeSH Supplementary Concept]
- 2,2'-pyridylisatogen tosylate [MeSH Supplementary Concept]
- 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate [MeSH Supplementary Concept]
- 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline [MeSH Supplementary Concept]
- 2,3-piperidinedicarboxylic acid [MeSH Supplementary Concept]
- 2,4-diethyl-1-methyl-3-(ethylsulfanylcarbonyl)-5-ethyloxycarbonyl-6-phenylpyridinium [MeSH Supplementary Concept]
- 2-((1-phenylpropyl)amino)adenosine [MeSH Supplementary Concept]
- 2-((phenylisopropyl)amino)adenosine [MeSH Supplementary Concept]
- 2-(1,1-dimethyl-1,3-dihydro-benzo(e)indol-2-ylidene)-malonaldehyde [MeSH Supplementary Concept]
- 2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-3(2H)-pyridazinone [MeSH Supplementary Concept]
- 2-(2-(6-methylaminopurin-9-yl)ethyl)propane-1,3-bisoxy(diammonium phosphate) [MeSH Supplementary Concept]
- 2-(2-phenylethoxy)adenosine [MeSH Supplementary Concept]
- 2-(3''-(6''-bromoindolyl)ethyloxy)adenosine [MeSH Supplementary Concept]
- 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)-5'-N-ethylcarboxamidoadenosine [MeSH Supplementary Concept]
- 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine [MeSH Supplementary Concept]
- 2-(4-methoxyphenyl)-1,2,4-triazolo(1,5-a)quinoxalin-4-one [MeSH Supplementary Concept]
- 2-(4-nitrophenyl)-1,2,4,5-tetrahydro-1,2,4-triazolo(4,3-a)quinoxaline-1,4-dione [MeSH Supplementary Concept]
- 2-Amino-5-phosphonovalerate [MeSH Descriptor]
- 2-Oxo-PCE [MeSH Supplementary Concept]
- 2-amino-3-((3,4-difluorophenyl)sulfanylmethyl)-4-hydroxy-bicyclo(3.1.0)hexane-2,6-dicarboxylic acid hydrochloride [MeSH Supplementary Concept]
- 2-amino-3-(3-(carboxymethoxy)-5-tert-butyl-4-isoxazolyl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-phosphonopropionic acid [MeSH Supplementary Concept]
- 2-amino-4-(3-trifluoromethylphenyl)-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile [MeSH Supplementary Concept]
- 2-amino-4-(4-hydroxyphenyl)-6-(1H-imidazol-2-ylmethylsulfanyl)pyridine-3,5-dicarbonitrile [MeSH Supplementary Concept]
- 2-amino-4-benzo(1,3)dioxol-5-yl-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile [MeSH Supplementary Concept]
- 2-amino-4-carboxy-7-(2-naphthyl)hept-6-enoic acid [MeSH Supplementary Concept]
- 2-amino-4-methyl-5-phosphono-3-pentenoic acid [MeSH Supplementary Concept]
- 2-amino-4-phosphonobutyric acid [MeSH Supplementary Concept]
- 2-amino-7-phosphonoheptanoic acid [MeSH Supplementary Concept]
- 2-aminoadipic acid [MeSH Descriptor]
- 2-chloro-5-hydroxyphenylglycine [MeSH Supplementary Concept]
- 2-chloro-N(6)-(3-iodobenzyl)-5'-N-methylcarbamoyl-4'-thioadenosine [MeSH Supplementary Concept]
- 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide [MeSH Supplementary Concept]
- 2-chloro-N(6)-methyladenosine-5'-methyluronamide [MeSH Supplementary Concept]
- 2-hexyloxyadenosine [MeSH Supplementary Concept]
- 2-methylthio-ATP [MeSH Supplementary Concept]
- 2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine [MeSH Supplementary Concept]
- 3,4',5-tri(glucose-3-O-succinyl)resveratrol [MeSH Supplementary Concept]
- 3,5-dihydroxyphenylglycine [MeSH Supplementary Concept]
- 3,6-dichloro-2'-isopropyloxy-4'-methylflavone [MeSH Supplementary Concept]
- 3,7-dimethyl-1-propargylxanthine [MeSH Supplementary Concept]
- 3-(2-(4-aminophenyl)ethyl)-8-benzyl-7-(2-ethyl(2-hydroxyethyl)aminoethyl)-1-propyl-3,7-dihydropurine-2,6-dione [MeSH Supplementary Concept]
- 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid [MeSH Supplementary Concept]
- 3-(3-hydroxypropyl)-8-(3-methoxystyryl)-7-methyl-1-propargylxanthine [MeSH Supplementary Concept]
- 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine [MeSH Supplementary Concept]
- 3-phenacyluridine diphosphate [MeSH Supplementary Concept]
- 4'-(2-chloro-6-(3-iodobenzylamino)purine)-2',3'-O-dihydroxy-bicyclo(3.1.0)hexane [MeSH Supplementary Concept]
- 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine [MeSH Supplementary Concept]
- 4-((4-(1-(ethoxycarbonyl)-1-methylethoxy)-7-methyl-2-quinolyl)carbamoyl)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxopentanoic acid [MeSH Supplementary Concept]
- 4-(2-iodo-6-methylaminopurin-9-yl)-1-((phosphato)methyl)-2-(phosphato)bicyclo(3.1.0)hexane [MeSH Supplementary Concept]
- 4-amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo(4,3-a)-quinoxalin-1-one [MeSH Supplementary Concept]
- 4-benzoylamino-2-(4-methoxyphenyl)pyrido(2,3-e)-1,2,4-triazolo(4,3-a)pyrazin-1-one [MeSH Supplementary Concept]
- 4-carboxyphenylglycine [MeSH Supplementary Concept]
- 4-dibenzoylamino-2-(4-methoxyphenyl)pyrazoloquinoline [MeSH Supplementary Concept]
- 4-diphenylacetylamino-2-phenylpyrazoloquinoline [MeSH Supplementary Concept]
- 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline [MeSH Supplementary Concept]
- 5'-O-ethyl-N-(3-iodobenzyl)adenosine [MeSH Supplementary Concept]
- 5,7-dichlorokynurenic acid [MeSH Supplementary Concept]
- 5-(((4-fluorosulfonylphenyl)amino)carbonyl)amino-8-n-propyl-2-(2-furyl)pyrazolol(4,3-e)1,2,4-triazolo(1,5-c)pyrimidine [MeSH Supplementary Concept]
- 5-(((4-pyridyl)amino)carbonyl)amino-8-methyl-2-(2-furyl)pyrazolo(4,3-e)1,2,4-triazolo(1,5-c)pyrimdiine [MeSH Supplementary Concept]
- 5-(5-amino-3-(4-fluorophenyl)pyrazin-2-yl)-1-isopropylprydine-2(1H)-one [MeSH Supplementary Concept]
- 5-N-methylimino-2-(3-methylphenyl)-3-phenyl-2H-(1,2,4)-thiadiazole [MeSH Supplementary Concept]
- 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine [MeSH Supplementary Concept]
- 5-oxazol-2-yl-1H-pyrazolo(4,3-b)pyridin-3-ylamine [MeSH Supplementary Concept]
- 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione [MeSH Supplementary Concept]
- 6-Cyano-7-nitroquinoxaline-2,3-dione [MeSH Descriptor]
- 6-methyl-2-(phenylethynyl)pyridine [MeSH Supplementary Concept]
- 6-methyl-7-(1,2,3)triazol-2-yl-1,6-dihydrobenzo(1,2-d-3,4-d')diimidazole [MeSH Supplementary Concept]
- 7,8-dihydro-8-ethyl-2-(4-bicyclo(2.2.2)octan-1-ol)-4-propyl-1H-imidazo(2,1-i)purin-5(4H)-one [MeSH Supplementary Concept]
- 7-chloro-4-hydroxy-2-phenyl-1,8-naphthyridine [MeSH Supplementary Concept]
- 7-chlorokynurenic acid [MeSH Supplementary Concept]
- 8,8',8'',8'''-(carbonylbis(imino-5,13-benzenetriyl-bis(carbonylimino)))tetrakisnaphthalene-1,3,5-trisulfonic acid [MeSH Supplementary Concept]
- 8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-1,3-dimethylxanthine [MeSH Supplementary Concept]
- 8-(4-(4-benzylpiperazide-1-sulfonyl)phenyl)-1-propylxanthine [MeSH Supplementary Concept]
- 8-(4-sulfophenyl)theophylline [MeSH Supplementary Concept]
- 8-butylamino-N(6)-cyclopentyladenosine [MeSH Supplementary Concept]
- 8-butylaminoadenosine [MeSH Supplementary Concept]
- 8-carboxy-iso-iantheran A [MeSH Supplementary Concept]
- 8-cyclohexylcaffeine [MeSH Supplementary Concept]
- 8-cyclopenta-3-(3-fluoropropyl)-1-propylxanthine [MeSH Supplementary Concept]
- 8-cyclopentyl-1,3-dimethylxanthine [MeSH Supplementary Concept]
- 8-cyclopentyl-2,6-diphenylpurine [MeSH Supplementary Concept]
- 8-cyclopentyl-3-(3-(4-fluorosulfonylbenzamido)propyl)-1-propylxanthine [MeSH Supplementary Concept]
- 8-cyclopentyl-3-(3-iodoprop-2-en-1-yl)-1-propylxanthine [MeSH Supplementary Concept]
- 8-dipropyl-8-cyclopentylxanthine [MeSH Supplementary Concept]
- 8-methylamino-N6-cyclopentyladenosine [MeSH Supplementary Concept]
- 9-butyl-2-(3-noradamantyl)-4,5-dihydro-6H,8H-pyrimido(1,2,3-cd)purine-8,10-dione [MeSH Supplementary Concept]
- 9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline [MeSH Supplementary Concept]
- 9-chloro-5-(4-methoxybenzoyl)amino-2-phenyl(1,2,3)triazolo(1,2-a)(1,2,4)benzotriazin-1-one [MeSH Supplementary Concept]
- ABEA-X-BY630 [MeSH Supplementary Concept]
- AR C109318XX [MeSH Supplementary Concept]
- ARC 118925XX [MeSH Supplementary Concept]
- AZ 11645373 [MeSH Supplementary Concept]
- BAY 60-6583 [MeSH Supplementary Concept]
- BCI-838 [MeSH Supplementary Concept]
- CF 502 [MeSH Supplementary Concept]
- CGP 39551 [MeSH Supplementary Concept]
- CGP 39653 [MeSH Supplementary Concept]
- CVT 2759 [MeSH Supplementary Concept]
- Clopidogrel [MeSH Descriptor]
- FG 9041 [MeSH Supplementary Concept]
- FSPTP pyrimidine [MeSH Supplementary Concept]
- Felbamate [MeSH Descriptor]
- GW 328267 [MeSH Supplementary Concept]
- GYKI 52466 [MeSH Supplementary Concept]
- GYKI 53655 [MeSH Supplementary Concept]
- Gabapentin [MeSH Descriptor]
- HU 211 [MeSH Supplementary Concept]
- INS 48823 [MeSH Supplementary Concept]
- INS 50589 [MeSH Supplementary Concept]
- JNJ-55308942 [MeSH Supplementary Concept]
- KF 17387 [MeSH Supplementary Concept]
- KF 20274 [MeSH Supplementary Concept]
- KFM 19 [MeSH Supplementary Concept]
- KMCP 98 [MeSH Supplementary Concept]
- L 701324 [MeSH Supplementary Concept]
- LJ-2698 [MeSH Supplementary Concept]
- LSP2-9166 [MeSH Supplementary Concept]
- LY 235959 [MeSH Supplementary Concept]
- LY 341495 [MeSH Supplementary Concept]
- MRE 3008-F20 [MeSH Supplementary Concept]
- MRS 1097 [MeSH Supplementary Concept]
- MRS 1204 [MeSH Supplementary Concept]
- MRS 1595 [MeSH Supplementary Concept]
- MRS 1740 [MeSH Supplementary Concept]
- MRS 1741 [MeSH Supplementary Concept]
- MRS 2219 [MeSH Supplementary Concept]
- MRS 2220 [MeSH Supplementary Concept]
- N(6)-(4-sulfophenyl)adenosine [MeSH Supplementary Concept]
- N(6)-benzyl-5'-N-ethylcarboxamidoadenosine [MeSH Supplementary Concept]
- N(6)-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine [MeSH Supplementary Concept]
- N(6)-cyclopentyladenosine [MeSH Supplementary Concept]
- N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate [MeSH Supplementary Concept]
- N-((1S,trans)-2-hydroxycyclopentyl)adenosine [MeSH Supplementary Concept]
- N-(2-(2-phenyl-6-(4-(3-phenylpropyl)piperazine-1-carbonyl)-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(phenyl)-8-methylpyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-yl)phenylacetamide [MeSH Supplementary Concept]
- N-(3-(2-pyridinyl)isoquinolin-1-yl)benzamidine [MeSH Supplementary Concept]
- N-(3-iodobenzyl)-5'-O-methyladenosine [MeSH Supplementary Concept]
- N-(4,6-diphenylpyrimidin-2-yl)butyramide [MeSH Supplementary Concept]
- N-(4-acetylphenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)acetamide [MeSH Supplementary Concept]
- N-(adamantan-1-ylmethyl)-5-((3-aminopyrrolidin-1-yl)methyl)-2-chlorobenzamide [MeSH Supplementary Concept]
- N-Methylaspartate [MeSH Descriptor]
- N6-(4-(((4-((((2-((((isothiocyanatophenyl)amino)thiocarbonyl)amino)ethyl)amino)carbonyl)methyl)anilino)carbonyl)methyl)phenyl)adenosine [MeSH Supplementary Concept]
- N6-methoxy-2-(4-acetylphenyl)ethynyl-5'-N-methylcarboxamidoadenosine [MeSH Supplementary Concept]
- NF 279 [MeSH Supplementary Concept]
- NP-1815-PX [MeSH Supplementary Concept]
- NPC 12626 [MeSH Supplementary Concept]
- PSB-0777 [MeSH Supplementary Concept]
- RS 74513-000 [MeSH Supplementary Concept]
- SCH 442416 [MeSH Supplementary Concept]
- SDZ EAA 494 [MeSH Supplementary Concept]
- Ticagrelor [MeSH Descriptor]
- UBP684 [MeSH Supplementary Concept]
- UBP753 [MeSH Supplementary Concept]
- VUF 5455 [MeSH Supplementary Concept]
- VUF 5472 [MeSH Supplementary Concept]
- VUF 8504 [MeSH Supplementary Concept]
- WRC 0571 [MeSH Supplementary Concept]
- adenosine [MeSH Descriptor]
- alanyl-prolyl-glycyl-tryptophanamide [MeSH Supplementary Concept]
- alpha-((4-(methylamino)-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide [MeSH Supplementary Concept]
- alpha-((4-amino-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide [MeSH Supplementary Concept]
- alpha-Endorphin [MeSH Descriptor]
- alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid [MeSH Descriptor]
- alpha-methyl-4-carboxyphenylglycine [MeSH Supplementary Concept]
- aminophylline [MeSH Descriptor]
- aminopyridine-3,5-dicarbonitrile [MeSH Supplementary Concept]
- aptiganel [MeSH Supplementary Concept]
- avermectin [MeSH Supplementary Concept]
- beta-Endorphin [MeSH Descriptor]
- beta-N-methylamino-L-alanine [MeSH Supplementary Concept]
- binodenoson [MeSH Supplementary Concept]
- bombesin [MeSH Descriptor]
- caffeine [MeSH Descriptor]
- cangrelor [MeSH Supplementary Concept]
- caroverine [MeSH Supplementary Concept]
- clopidogrel carboxylic acid [MeSH Supplementary Concept]
- conantokin-T [MeSH Supplementary Concept]
- conotoxin GV [MeSH Supplementary Concept]
- delta sleep-inducing peptide [MeSH Descriptor]
- dextromethorphan [MeSH Descriptor]
- dextrorphan [MeSH Descriptor]
- dizocilpine maleate [MeSH Descriptor]
- dynorphins [MeSH Descriptor]
- eglumetad [MeSH Supplementary Concept]
- eledoisin [MeSH Descriptor]
- eliprodil [MeSH Supplementary Concept]
- endorphins [MeSH Descriptor]
- enkephalin, ala(2)-mephe(4)-gly(5)- [MeSH Descriptor]
- enkephalin, d-penicillamine (2,5)- [MeSH Descriptor]
- enkephalin, leucine [MeSH Descriptor]
- enkephalin, methionine [MeSH Descriptor]
- enkephalins [MeSH Descriptor]
- enprofylline [MeSH Supplementary Concept]
- ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate [MeSH Supplementary Concept]
- excitatory amino acids [MeSH Descriptor]
- gacyclidine [MeSH Supplementary Concept]
- gamma-Endorphin [MeSH Descriptor]
- glutamic acid diethyl ester [MeSH Supplementary Concept]
- ibogaine [MeSH Descriptor]
- ibotenic acid [MeSH Descriptor]
- iso-iantheran A [MeSH Supplementary Concept]
- iso-iantheran B [MeSH Supplementary Concept]
- isopropyl 1-(2-chloro-2-phenylethyl)-4-((2-(4-methoxyphenyl)ethyl)amino)-1H-pyrazolo(3,4-b)pyridine-5-carboxylate [MeSH Supplementary Concept]
- istradefylline [MeSH Supplementary Concept]
- kainic acid [MeSH Descriptor]
- kaitocephalin [MeSH Supplementary Concept]
- kassinin [MeSH Descriptor]
- ketamine [MeSH Descriptor]
- ketobemidone [MeSH Supplementary Concept]
- kynurenic acid [MeSH Descriptor]
- licostinel [MeSH Supplementary Concept]
- methyl 1-(2-chloro-2-phenylethyl)-4-((2-(4-methoxyphenyl)ethyl)amino)-1H-pyrazolo(3,4-b)pyridine-5-carboxylate [MeSH Supplementary Concept]
- neurokinin B [MeSH Descriptor]
- neurokinin a [MeSH Descriptor]
- opioid peptides [MeSH Descriptor]
- phencyclidine [MeSH Descriptor]
- physalaemin [MeSH Descriptor]
- pituitary adenylate cyclase-activating polypeptide [MeSH Descriptor]
- propyl 1-ethyl-8-oxo-3-phenyl-5,6,7,8-tetrahydro-7-thiaisoquinoline-4-carboxylate [MeSH Supplementary Concept]
- pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) [MeSH Supplementary Concept]
- quisqualic acid [MeSH Descriptor]
- regadenoson [MeSH Supplementary Concept]
- riluzole [MeSH Descriptor]
- selfotel [MeSH Supplementary Concept]
- substance P [MeSH Descriptor]
- tachykinins [MeSH Descriptor]
- tecadenoson [MeSH Supplementary Concept]
- theophylline [MeSH Descriptor]
- ticlopidine [MeSH Descriptor]
- uridine-5'-O-(3-thiotriphosphate) [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients